Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Dyskinesias in Parkinson's Disease
NCT02162979Phase 2Terminated
- Sponsor
- Loma Linda University
- Start
- Feb 2002
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sildenafil in dyskinesia, sponsored by Loma Linda University. Started Feb 2002; status: terminated.
02
Drugs
sildenafil
03
Conditions
dyskinesia
Beyond the preview
Go deeper on NCT02162979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02162979.